Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Scienta
Scienta Lab uses AI to translate early experimental signals into predicted patient outcomes for immune-mediated diseases, reducing the preclinical–clinical gap in drug development. The company…
Scienta
Scienta Lab uses AI to translate early experimental signals into predicted patient outcomes for immune-mediated diseases, reducing the preclinical–clinical gap in drug development. The company…
TL;DR
What they do: Build EVA, a foundation AI model that predicts human immune responses to improve translational research in immunology and inflammatory diseases.
Headquarters: Paris (France)
Founding year: 2021
Stage / funding signal: Seed-stage funding; recipient of EIC Accelerator support
Team size: ~20 employees
Company Overview
Problem Domain
Translational immunology / drug development for immune-mediated and inflammatory diseases
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
7220894
Company reported recipients and supporters include EIC Accelerator and a mix of investors; public profiles list multiple funding rounds (4) with seed as last round.
Investor Signal
“Recipient of European Innovation Council / EIC Accelerator support; investors include CentraleSupélec Venture, Flavien Kulawik, Guillaume Amblard, PharmStars”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,300+
New This Week